DYAX CORP Patent Applications Pending
3 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2024-11-14: Application 18947795; Invention ACTRIIB BINDING AGENTS AND USES THEREOF; Applicant Dyax Corp.; Status Docketed New Case - Ready for Examination.
- 2021-10-08: Application PCTUS2021054195; Invention METHODS AND APPARATUSES FOR MODELING ADAMTS13 AND VON WILLEBRAND FACTOR INTERACTIONS; Applicant DYAX CORP.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
- 2019-03-14: Application 62818189; Invention TREATING HEREDITARY ANGIOEDEMA ATTACK WITH REDUCED DOSAGE OF ANTIBODIES BINDING TO HUMAN PLASMA KALLIKREIN; Applicant Dyax Corp.; Status Provisional Application Expired.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2024-11-14 | 18947795 | ACTRIIB BINDING AGENTS AND USES THEREOF | Dyax Corp. Acceleron Pharma Inc. | Docketed New Case - Ready for Examination | US20250066488A1 | Ravindra Kumar Asya Grinberg Monique Davies Diana Martik Janja Cosic Rachel Kent David Buckler | United States United States United States United States United States United States United States | CENTRAL, DOCKET |
| 2021-10-08 | PCTUS2021054195 | METHODS AND APPARATUSES FOR MODELING ADAMTS13 AND VON WILLEBRAND FACTOR INTERACTIONS | DYAX CORP. | RO PROCESSING COMPLETED-PLACED IN STORAGE | HOA Q. NGUYEN | United States | ||
| 2019-03-14 | 62818189 | TREATING HEREDITARY ANGIOEDEMA ATTACK WITH REDUCED DOSAGE OF ANTIBODIES BINDING TO HUMAN PLASMA KALLIKREIN | Dyax Corp. | Provisional Application Expired | Joan Yesid Mendivil Medina | Switzerland |